01.22.24 -- An Uncertain Future For Interchangeability

The company’s a bit larger than those we typically cover, and that’s okay! Sometimes, the smartest approach to creating your own masterpiece is to study the masters. On the Business of Biotech, we sit down with Incyte’s Group Vice President and head of its Inflammation and AutoImmunity Group, Dr. Jim Lee, for a dissection of their approach to the comprehensive and efficient R&D that leads to repeated clinical and commercial success.

Join us January 23 as we dive deeper into the common red flags to look for, the critical questions to ask, and best practices for safeguarding your trial’s budget. Click here to learn more.

The pharma industry is identifying ways to make processes more sustainable. Learn how nanoparticle engineering technology can both empower sustainability goals and lead to better patient outcomes.

BsAbs’ dual specificity opens a wide range of applications. Understand why consistent production of structurally complex molecules that exhibit high yield and purity requires keen expertise and experience.

Several technologies are available for microencapsulating drugs. Finding the right CDMO to optimize a drug’s efficacy and manufacturing during formulation is integral to its clinical and commercial success.